Found 0 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
PHASE2Researchers conducting this study hope to learn about the safety and effect...
Location
University of Chicago Comprehensive Cancer Center
A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis
PHASE2The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
The Effects of Cervical Stabilization Exercise Training With Telerehabilitation in Individuals With Migraine
NAThe aim of our study is to investigate the effects of cervical stabilizatio...
Location
Multiple Locations
Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects
PHASE1Study to determine the effect of multiple-dose BBT-877 on the single-dose p...
Evaluation of the Efficacy of an Antioxidant Dressing in Chronic Wound Healing
NAThe aim of this study is to compare the effect of antioxidant dressing (act...
Location
Universidad de Jaén
The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels
PHASE4To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and E...
Location
Multiple Locations
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
PHASE3Compile acute (30-day) clinical outcomes data and 9-month angiographic and ...
Location
St. Vincent's Hospital - Sydney
Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.
PHASE1This is a randomized, double-blind, active drug- and placebo-controlled, do...
Location
The Third Xiangya Hospital of Central South University
Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)
PHASE1This trial is a prospective, multi-center, randomized comparison study of 2...
Location
Multiple Locations
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
PHASE2Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Location
Fudan University Shanghai Cancer Center